purchase customization

1 Introduction to Research & Analysis Reports
1.1 Biologics and Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologics and Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologics and Biosimilars Overall Market Size
2.1 Global Biologics and Biosimilars Market Size: 2022 VS 2029
2.2 Global Biologics and Biosimilars Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biologics and Biosimilars Sales: 2018-2029
3 Company Landscape
3.1 Top Biologics and Biosimilars Players in Global Market
3.2 Top Global Biologics and Biosimilars Companies Ranked by Revenue
3.3 Global Biologics and Biosimilars Revenue by Companies
3.4 Global Biologics and Biosimilars Sales by Companies
3.5 Global Biologics and Biosimilars Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biologics and Biosimilars Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biologics and Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologics and Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Biologics and Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologics and Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biologics and Biosimilars Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Erythropoietin
4.1.5 Insulin
4.1.6 Vaccines
4.1.7 Others
4.2 By Type - Global Biologics and Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biologics and Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global Biologics and Biosimilars Revenue, 2024-2029
4.2.3 By Type - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
4.3 By Type - Global Biologics and Biosimilars Sales & Forecasts
4.3.1 By Type - Global Biologics and Biosimilars Sales, 2018-2023
4.3.2 By Type - Global Biologics and Biosimilars Sales, 2024-2029
4.3.3 By Type - Global Biologics and Biosimilars Sales Market Share, 2018-2029
4.4 By Type - Global Biologics and Biosimilars Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biologics and Biosimilars Market Size, 2022 & 2029
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Others
5.2 By Application - Global Biologics and Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biologics and Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global Biologics and Biosimilars Revenue, 2024-2029
5.2.3 By Application - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
5.3 By Application - Global Biologics and Biosimilars Sales & Forecasts
5.3.1 By Application - Global Biologics and Biosimilars Sales, 2018-2023
5.3.2 By Application - Global Biologics and Biosimilars Sales, 2024-2029
5.3.3 By Application - Global Biologics and Biosimilars Sales Market Share, 2018-2029
5.4 By Application - Global Biologics and Biosimilars Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Biologics and Biosimilars Market Size, 2022 & 2029
6.2 By Region - Global Biologics and Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biologics and Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global Biologics and Biosimilars Revenue, 2024-2029
6.2.3 By Region - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
6.3 By Region - Global Biologics and Biosimilars Sales & Forecasts
6.3.1 By Region - Global Biologics and Biosimilars Sales, 2018-2023
6.3.2 By Region - Global Biologics and Biosimilars Sales, 2024-2029
6.3.3 By Region - Global Biologics and Biosimilars Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Biologics and Biosimilars Revenue, 2018-2029
6.4.2 By Country - North America Biologics and Biosimilars Sales, 2018-2029
6.4.3 US Biologics and Biosimilars Market Size, 2018-2029
6.4.4 Canada Biologics and Biosimilars Market Size, 2018-2029
6.4.5 Mexico Biologics and Biosimilars Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Biologics and Biosimilars Revenue, 2018-2029
6.5.2 By Country - Europe Biologics and Biosimilars Sales, 2018-2029
6.5.3 Germany Biologics and Biosimilars Market Size, 2018-2029
6.5.4 France Biologics and Biosimilars Market Size, 2018-2029
6.5.5 U.K. Biologics and Biosimilars Market Size, 2018-2029
6.5.6 Italy Biologics and Biosimilars Market Size, 2018-2029
6.5.7 Russia Biologics and Biosimilars Market Size, 2018-2029
6.5.8 Nordic Countries Biologics and Biosimilars Market Size, 2018-2029
6.5.9 Benelux Biologics and Biosimilars Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Biologics and Biosimilars Revenue, 2018-2029
6.6.2 By Region - Asia Biologics and Biosimilars Sales, 2018-2029
6.6.3 China Biologics and Biosimilars Market Size, 2018-2029
6.6.4 Japan Biologics and Biosimilars Market Size, 2018-2029
6.6.5 South Korea Biologics and Biosimilars Market Size, 2018-2029
6.6.6 Southeast Asia Biologics and Biosimilars Market Size, 2018-2029
6.6.7 India Biologics and Biosimilars Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Biologics and Biosimilars Revenue, 2018-2029
6.7.2 By Country - South America Biologics and Biosimilars Sales, 2018-2029
6.7.3 Brazil Biologics and Biosimilars Market Size, 2018-2029
6.7.4 Argentina Biologics and Biosimilars Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biologics and Biosimilars Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Biologics and Biosimilars Sales, 2018-2029
6.8.3 Turkey Biologics and Biosimilars Market Size, 2018-2029
6.8.4 Israel Biologics and Biosimilars Market Size, 2018-2029
6.8.5 Saudi Arabia Biologics and Biosimilars Market Size, 2018-2029
6.8.6 UAE Biologics and Biosimilars Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologics and Biosimilars Major Product Offerings
7.1.4 Roche Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biologics and Biosimilars Major Product Offerings
7.2.4 Amgen Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biologics and Biosimilars Major Product Offerings
7.3.4 AbbVie Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Sanofi-Aventis
7.4.1 Sanofi-Aventis Company Summary
7.4.2 Sanofi-Aventis Business Overview
7.4.3 Sanofi-Aventis Biologics and Biosimilars Major Product Offerings
7.4.4 Sanofi-Aventis Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi-Aventis Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biologics and Biosimilars Major Product Offerings
7.5.4 Johnson & Johnson Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biologics and Biosimilars Major Product Offerings
7.6.4 Pfizer Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Biologics and Biosimilars Major Product Offerings
7.7.4 Novo Nordisk Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Biologics and Biosimilars Major Product Offerings
7.8.4 Eli Lilly Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Biologics and Biosimilars Major Product Offerings
7.9.4 Novartis Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biologics and Biosimilars Major Product Offerings
7.10.4 Merck Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 3sbio
7.11.1 3sbio Company Summary
7.11.2 3sbio Biologics and Biosimilars Business Overview
7.11.3 3sbio Biologics and Biosimilars Major Product Offerings
7.11.4 3sbio Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 3sbio Key News & Latest Developments
7.12 Changchun High Tech
7.12.1 Changchun High Tech Company Summary
7.12.2 Changchun High Tech Biologics and Biosimilars Business Overview
7.12.3 Changchun High Tech Biologics and Biosimilars Major Product Offerings
7.12.4 Changchun High Tech Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.12.5 Changchun High Tech Key News & Latest Developments
7.13 CP Guojian
7.13.1 CP Guojian Company Summary
7.13.2 CP Guojian Biologics and Biosimilars Business Overview
7.13.3 CP Guojian Biologics and Biosimilars Major Product Offerings
7.13.4 CP Guojian Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.13.5 CP Guojian Key News & Latest Developments
7.14 Biotech
7.14.1 Biotech Company Summary
7.14.2 Biotech Business Overview
7.14.3 Biotech Biologics and Biosimilars Major Product Offerings
7.14.4 Biotech Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.14.5 Biotech Key News & Latest Developments
7.15 Gelgen
7.15.1 Gelgen Company Summary
7.15.2 Gelgen Business Overview
7.15.3 Gelgen Biologics and Biosimilars Major Product Offerings
7.15.4 Gelgen Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.15.5 Gelgen Key News & Latest Developments
7.16 Innovent
7.16.1 Innovent Company Summary
7.16.2 Innovent Business Overview
7.16.3 Innovent Biologics and Biosimilars Major Product Offerings
7.16.4 Innovent Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.16.5 Innovent Key News & Latest Developments
7.17 Dong Bao
7.17.1 Dong Bao Company Summary
7.17.2 Dong Bao Business Overview
7.17.3 Dong Bao Biologics and Biosimilars Major Product Offerings
7.17.4 Dong Bao Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.17.5 Dong Bao Key News & Latest Developments
7.18 Ganlee
7.18.1 Ganlee Company Summary
7.18.2 Ganlee Business Overview
7.18.3 Ganlee Biologics and Biosimilars Major Product Offerings
7.18.4 Ganlee Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.18.5 Ganlee Key News & Latest Developments
7.19 United Laboratories
7.19.1 United Laboratories Company Summary
7.19.2 United Laboratories Business Overview
7.19.3 United Laboratories Biologics and Biosimilars Major Product Offerings
7.19.4 United Laboratories Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.19.5 United Laboratories Key News & Latest Developments
8 Global Biologics and Biosimilars Production Capacity, Analysis
8.1 Global Biologics and Biosimilars Production Capacity, 2018-2029
8.2 Biologics and Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologics and Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biologics and Biosimilars Supply Chain Analysis
10.1 Biologics and Biosimilars Industry Value Chain
10.2 Biologics and Biosimilars Upstream Market
10.3 Biologics and Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologics and Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer